Abstract
Currently, there is ongoing discussion about the timing and methods of tracheostomy in patients infected with Covid-19 and in need of artificial lung ventilation. The object of the study was 182 patients with Covid-19 who were on artificial lung ventilation. At the initial stage of tracheostomy, Covid-19 infected patients had complications in the form of intra- and postoperative bleeding (diffuse) against the background of continued titration of heparin (12 cases out of 26, – 46.1%). In 75.8% of cases, tracheostomy was performed within 3 to 14 days of being on artificial lung ventilation, in 24.2% of cases – within 14 days of being on artificial lung ventilation. Indications for tracheostomy, including the timing and method of its implementation, in patients with Covid-19 who are on artificial lung ventilation should take into account the clinical and laboratory indicators of the severity of the condition and the likelihood of a favorable prognosis, the availability of safety resources for health workers involved in the operation and management of the postoperative period, as well as the possibility of constant dynamic monitoring of the patient.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call